- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04847180
Study of the Antipodal Capsular Fold and Its Potential Role in Antero-inferior Glenohumeral Instability (INSTABIO)
July 15, 2026 updated by: GCS Ramsay Santé pour l'Enseignement et la Recherche
Study of the Antipodal Capsular Fold and Its Potential Role in Antero-inferior Glenohumeral Instability - Instabio
In schoulders instabilty, the soft tissue has not been the subject of histological studies, as has the "bare area" or zone devoid of cartilage, the exact role of which in glenohumeral biomechanics is unknown.
This research is based on the hypothesis that the antipodal lesions are constant, underestimated and that an architectural disorganization at the capsulo-ligament level could contribute to the instability of the shoulder.
The aim of this study is therefore to better characterize these lesions which could be the subject of a complementary stabilization procedure even in the absence of a humeral notch
Study Overview
Detailed Description
Surgery for unstable shoulders sometimes involves repairing lesions that promote instability.
These lesions are identified on imaging before surgery and then during the operation, but they are macroscopically inconsistent on genuine unstable shoulders.
While the importance of posterior capsuloligamentous structures (soft tissue) in antero-inferior stability has been the subject of biomechanical studies, the soft tissue has not been the subject of histological studies, as has the "bare area" or zone devoid of cartilage, the exact role of which in glenohumeral biomechanics is unknown.
However, this research is based on the hypothesis that the antipodal lesions are constant, underestimated and that an architectural disorganization at the capsulo-ligament level could contribute to the instability of the shoulder.
The aim of this study is therefore to better characterize these lesions which could be the subject of a complementary stabilization procedure even in the absence of a humeral notch.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Saint-Jean, France, 31240
- Clinique de l'Union
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
Instability Group
- Patient, male or female, over 18 years old and up to 40 years old
- Patient operated for antero-inferior shoulder instability
- Subject affiliated or beneficiary of a social security scheme
- Patient having signed the free and informed consent comparativ group
- Patient, male or female, over 18 years old and up to 40 years old
- Patient operated for a reason other than unstable shoulder
- Subject affiliated or beneficiary of a social security scheme
- Patient having signed the free and informed cons
Exclusion Criteria:
- History of surgery on the affected shoulder
- Capsuloligamentous disease (Ehler Danlos)
- History of instability (dislocation, subluxation) in witnesses
- Patient participating in another clinical study
- Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision;
- Pregnant, breastfeeding or parturient woman;
- Patient hospitalized without consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Instability shoulder group
Patients operated for an antero-inferior shoulder instability
|
The biopsy will be performed at the level of the capsular fold located just above the area devoid of cartilage in the postero-superior region of the humeral head, near the area where Hill Sachs notches occur.
|
|
Other: Non instability shoulder group
Patients without shoulder instability, operated for another reason.
|
The biopsy will be performed at the level of the capsular fold located just above the area devoid of cartilage in the postero-superior region of the humeral head, near the area where Hill Sachs notches occur.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Capsule Aspect
Time Frame: during biopsy
|
Normal capsule versus pathological capsule (abnormal capsule with disorganized framework, fragmented fibers, coiled )
|
during biopsy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Régis GUINAND, Dr, Clinique de l'Union - Ramsay-santé
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 26, 2020
Primary Completion (Actual)
January 12, 2024
Study Completion (Actual)
February 11, 2024
Study Registration Dates
First Submitted
April 12, 2021
First Submitted That Met QC Criteria
April 14, 2021
First Posted (Actual)
April 19, 2021
Study Record Updates
Last Update Posted (Actual)
July 16, 2026
Last Update Submitted That Met QC Criteria
July 15, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ID-RCB : 2019-A00859-48
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.